Gold Sponsor

Numerate is a privately-held data-driven drug design company that is transforming the discovery of new medicines that fill significant therapeutic gaps by applying our proprietary artificial intelligence algorithms at cloud-scale through incorporation of the ever-increasing amounts of public and private drug discovery data. Numerate’s drug design platform combines advances in computer science and statistics with traditional medicinal chemistry approaches to overcome major challenges in small molecule drug discovery and significantly accelerate candidate selection and optimization. Using this platform, coupled with innovative funding and partnership models, Numerate is collaborating with many large pharmaceutical companies around a strategic portfolio of drug discovery and data sharing and modeling programs. Numerate is also developing a therapeutic pipeline focused on producing first-in-class candidates against emerging targets addressing major unmet medical needs in cardiovascular, metabolic and neurodegenerative disease.



Contact us

To sponsor or exhibit contact:
Alistair Wilmot
+44 (0)207 092 1174

To speak:
Chris Shanks
+44 (0)207 092 1151